This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bennett, D. C. Articles by Hart, I. R. Search for Related Content PubMed PubMed Citation Articles by Bennett, D. C. Articles by Hart, I. R.

Increased Experimental Metastatic Capacity of a Murine Melanoma following Induction of Differentiation

Department of Anatomy, St. George's Hospital Medical School, Cranmer Terrace, Tooting, London SW17 ORE [D. C. B., T. J. D.], and Imperial Cancer Research Fund Laboratories, P. O. Box 123, Lincoln's Inn Fields, London WC2A 3PX [E. J. O., I. R. H.], England

Because of the interest in possible links between defective differentiation and cellular malignancy, the effects were examined of induced cell differentiation upon the experimental metastatic potential of the sublines F1 and F10 of the B16 mouse melanoma. These cell lines normally have low and high rates, respectively, of colonization of the lungs of mice after i.v. injection. Cellular differentiation was assessed by pigmentation and tyrosinase activity. In both cell lines, low and high levels of differentiation could reproducibly be generated by culture, respectively, at a low extracellular pH and at a higher pH in the presence of a melanocyte-stimulating hormone.

Surprisingly, in both lines the cells grown under conditions promoting differentiation showed a markedly higher rate of experimental metastasis, despite their slower proliferation in culture and in subcutaneous tumor implants, than the poorly differentiated cells. Radiolabeled well- and poorly pigmented cells were not initially deposited at significantly different rates in the lungs of mice after i.v. injection. However, subsequent retention in the lungs fell more quickly for the poorly differentiated cells. As indicated by tests in vitro, this difference appears not to be due to differential cytotoxicity by either host macrophages or natural killer cells, and it is under further study.

¹ Supported by a grant from the Cancer Research Campaign.

Received 12/ 4/85. Revised 2/26/86. Accepted 3/17/86.

This article has been cited by other articles:

				E. Sanz-Navares, N. Fernandez, M. G. Kazanietz, and S. A. Rotenberg Atypical Protein Kinase C{zeta} Suppresses Migration of Mouse Melanoma Cells Cell Growth Differ., October 1, 2001; 12(10): 517 - 524. [Abstract] [Full Text] [PDF]

				Y. FUNASAKA, H. SATO, and M. ICHIHASHI Expression of Corticotropin Releasing Hormone in Malignant Melanoma Ann. N.Y. Acad. Sci., October 20, 1999; 885(1): 391 - 393. [Full Text] [PDF]

				M. Rachkovsky and J. Pawelek Acquired Melanocyte Stimulating Hormone-inducible Chemotaxis following Macrophage Fusion with Cloudman S91 Melanoma Cells Cell Growth Differ., July 1, 1999; 10(7): 517 - 524. [Abstract] [Full Text]

				D Rusciano, P Lorenzoni, and M. Burger Regulation of c-met expression in B16 murine melanoma cells by melanocyte stimulating hormone J. Cell Sci., January 3, 1999; 112(5): 623 - 630. [Abstract] [PDF]